Servier Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Servier Pharmaceuticals's estimated annual revenue is currently $248.6M per year.
- Servier Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Servier Pharmaceuticals has 1237 Employees.
- Servier Pharmaceuticals grew their employee count by 5% last year.
Servier Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Compliance & Legal | Reveal Email/Phone |
3 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
4 | Chief Staff | Reveal Email/Phone |
5 | Executive Assistant to Chief Medical Officer | Reveal Email/Phone |
6 | Chief Operating Officer R&D, USA | Reveal Email/Phone |
7 | R&D Chief Operating Officer | Reveal Email/Phone |
8 | Chief Commercial Officer | Reveal Email/Phone |
9 | Chief Business Officer | Reveal Email/Phone |
10 | EVP, United States | Reveal Email/Phone |
Servier Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Servier Pharmaceuticals?
Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients' lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all.
keywords:N/AN/A
Total Funding
1237
Number of Employees
$248.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Servier Pharmaceuticals News
Servier Pharmaceuticals LLC is a commercial-stage company with a passion for innovation and improving the lives of patients, their families...
(Funded by Agios Pharmaceuticals and Servier Pharmaceuticals; AGILE ClinicalTrials.gov number, NCT03173248. opens in new tab.)...
The study was funded by Agios Pharmaceuticals. Servier Pharmaceuticals has completed the acquisition of the Agios oncology business.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $468.7M | 1240 | 4% | N/A |
#2 | $468.7M | 1240 | 9% | N/A |
#3 | $254.7M | 1272 | 441% | N/A |
#4 | $265.8M | 1282 | -4% | $38M |
#5 | $430.2M | 1282 | 1% | N/A |